Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability | Adolescent Medicine | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.173.234.169. Please contact the publisher to request reinstatement.
1.
Siegel  RL, Miller  KD, Jemal  A.  Cancer statistics, 2019.   CA Cancer J Clin. 2019;69(1):7-34. doi:10.3322/caac.21551 PubMedGoogle ScholarCrossref
2.
Smith  MA, Seibel  NL, Altekruse  SF,  et al.  Outcomes for children and adolescents with cancer: challenges for the twenty-first century.   J Clin Oncol. 2010;28(15):2625-2634. doi:10.1200/JCO.2009.27.0421 PubMedGoogle ScholarCrossref
3.
Robison  LL, Armstrong  GT, Boice  JD,  et al.  The Childhood Cancer Survivor Study: a National Cancer Institute–supported resource for outcome and intervention research.   J Clin Oncol. 2009;27(14):2308-2318. doi:10.1200/JCO.2009.22.3339 PubMedGoogle ScholarCrossref
4.
Barr  RD, Ferrari  A, Ries  L, Whelan  J, Bleyer  WA.  Cancer in adolescents and young adults: a narrative review of the current status and a view of the future.   JAMA Pediatr. 2016;170(5):495-501. doi:10.1001/jamapediatrics.2015.4689 PubMedGoogle ScholarCrossref
5.
Zeng  C, Wen  W, Morgans  AK, Pao  W, Shu  XO, Zheng  W.  Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.   JAMA Oncol. 2015;1(1):88-96. doi:10.1001/jamaoncol.2014.161 PubMedGoogle ScholarCrossref
6.
Siegel  R, Ward  E, Brawley  O, Jemal  A.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.   CA Cancer J Clin. 2011;61(4):212-236. doi:10.3322/caac.20121 PubMedGoogle ScholarCrossref
7.
Pui  CH, Pei  D, Pappo  AS,  et al.  Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children’s Research Hospital, 1992 through 2007.   J Clin Oncol. 2012;30(16):2005-2012. doi:10.1200/JCO.2011.40.8617 PubMedGoogle ScholarCrossref
8.
Bhatia  S.  Disparities in cancer outcomes: lessons learned from children with cancer.   Pediatr Blood Cancer. 2011;56(6):994-1002. doi:10.1002/pbc.23078 PubMedGoogle ScholarCrossref
9.
Ward  E, DeSantis  C, Robbins  A, Kohler  B, Jemal  A.  Childhood and adolescent cancer statistics, 2014.   CA Cancer J Clin. 2014;64(2):83-103. doi:10.3322/caac.21219 PubMedGoogle ScholarCrossref
10.
Truong  B, Green  AL, Friedrich  P, Ribeiro  KB, Rodriguez-Galindo  C.  Ethnic, racial, and socioeconomic disparities in retinoblastoma.   JAMA Pediatr. 2015;169(12):1096-1104. doi:10.1001/jamapediatrics.2015.2360 PubMedGoogle ScholarCrossref
11.
Linabery  AM, Ross  JA.  Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999.   Cancer. 2008;113(9):2575-2596. doi:10.1002/cncr.23866 PubMedGoogle ScholarCrossref
12.
Kadan-Lottick  NS, Ness  KK, Bhatia  S, Gurney  JG.  Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.   JAMA. 2003;290(15):2008-2014. doi:10.1001/jama.290.15.2008 PubMedGoogle ScholarCrossref
13.
Kahn  JM, Keegan  TH, Tao  L, Abrahão  R, Bleyer  A, Viny  AD.  Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.   Cancer. 2016;122(17):2723-2730. doi:10.1002/cncr.30089 PubMedGoogle ScholarCrossref
14.
Tehranifar  P, Neugut  AI, Phelan  JC,  et al.  Medical advances and racial/ethnic disparities in cancer survival.   Cancer Epidemiol Biomarkers Prev. 2009;18(10):2701-2708. doi:10.1158/1055-9965.EPI-09-0305 PubMedGoogle Scholar
15.
Tehranifar  P, Goyal  A, Phelan  JC,  et al.  Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality.   Cancer Causes Control. 2016;27(4):553-560. doi:10.1007/s10552-016-0729-2 PubMedGoogle ScholarCrossref
16.
Mahal  BA, Berman  RA, Taplin  ME, Huang  FW.  Prostate cancer–specific mortality across Gleason scores in black vs nonblack men.   JAMA. 2018;320(23):2479-2481. doi:10.1001/jama.2018.11716 PubMedGoogle ScholarCrossref
17.
Phelan  JC, Link  BG, Tehranifar  P.  Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications.   J Health Soc Behav. 2010;51(suppl):S28-S40. doi:10.1177/0022146510383498 PubMedGoogle ScholarCrossref
18.
Surveillance, Epidemiology, and End Results Program Database. Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2018 Sub (1975-2016 varying)—Linked To County Attributes—Total US, 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018 submission. http://www.seer.cancer.gov. Accessed November 30, 2019.
19.
Surveillance, Epidemiology, and End Results Program. ICCC Recode ICD-O-3/WHO 2008. https://seer.cancer.gov/iccc/iccc-who2008.html. Accessed November 25, 2018.
20.
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat. Relative survival. https://seer.cancer.gov/seerstat/WebHelp/Relative_Survival.htm. Accessed June 21, 2019.
21.
Surveillance Research Program; National Cancer Institute. SEER*Stat software, version 8.3.6. https://seer.cancer.gov/seerstat. Updated August 8, 2019. Accessed August 10, 2019.
22.
UCLA Statistical Consulting Group. Statistical consulting. How can I test contrasts in R? R FAQ. https://stats.idre.ucla.edu/r/faq/how-can-i-test-contrasts-in-r/. Accessed November 1, 2019.
23.
Textor  J, van der Zander  B, Gilthorpe  MS, Liskiewicz  M, Ellison  GT.  Robust causal inference using directed acyclic graphs: the R package ‘dagitty’.   Int J Epidemiol. 2016;45(6):1887-1894. doi:10.1093/ije/dyw341PubMedGoogle Scholar
24.
Pearl  J.  Causality: Models, Reasoning, and Inference. 2nd ed. New York: Cambridge University Press; 2009. doi:10.1017/CBO9780511803161
25.
Cologne  J, Hsu  WL, Abbott  RD,  et al.  Proportional hazards regression in epidemiologic follow-up studies: an intuitive consideration of primary time scale.   Epidemiology. 2012;23(4):565-573. doi:10.1097/EDE.0b013e318253e418 PubMedGoogle ScholarCrossref
26.
Surveillance, Epidemiology, and End Results Program. Calculation of survival time fields. https://seer.cancer.gov/survivaltime/SurvivalTimeCalculation.pdf. Updated September 11, 2013. Accessed November 3, 2019.
27.
Bellera  CA, MacGrogan  G, Debled  M, de Lara  CT, Brouste  V, Mathoulin-Pélissier  S.  Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.   BMC Med Res Methodol. 2010;10:20. doi:10.1186/1471-2288-10-20 PubMedGoogle ScholarCrossref
28.
GitHub. kiJohnson/amenability-paper. https://github.com/kijohnson/Amenability-paper. Accessed November 6, 2019.
29.
Children’s Oncology Group. About us. https://www.childrensoncologygroup.org/index.php/aboutus. Accessed April 10, 2019.
30.
Miller  KD, Siegel  RL, Lin  CC,  et al.  Cancer treatment and survivorship statistics, 2016.   CA Cancer J Clin. 2016;66(4):271-289. doi:10.3322/caac.21349 PubMedGoogle ScholarCrossref
31.
O’Leary  M, Krailo  M, Anderson  JR, Reaman  GH; Children’s Oncology Group.  Progress in childhood cancer: 50 years of research collaboration, a report from the Children’s Oncology Group.   Semin Oncol. 2008;35(5):484-493. doi:10.1053/j.seminoncol.2008.07.008 PubMedGoogle ScholarCrossref
32.
Artiga  S, Ubri  P. Key issues in children's health coverage. Kaiser Family Foundation website. https://www.kff.org/medicaid/issue-brief/key-issues-in-childrens-health-coverage/. Published February 15, 2017. Accessed April 15, 2019.
33.
Kehm  RD, Spector  LG, Poynter  JN, Vock  DM, Altekruse  SF, Osypuk  TL.  Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?   Cancer. 2018;124(20):4090-4097. doi:10.1002/cncr.31560 PubMedGoogle ScholarCrossref
34.
Dess  RT, Hartman  HE, Mahal  BA,  et al.  Association of black race with prostate cancer–specific and other-cause mortality.   JAMA Oncol. 2019;5(7):975-983. doi:10.1001/jamaoncol.2019.0826 PubMedGoogle ScholarCrossref
35.
Link  BG, Phelan  J.  Social conditions as fundamental causes of disease.   J Health Soc Behav. 1995;(spec No):80-94. doi:10.2307/2626958 PubMedGoogle Scholar
36.
Colton  MD, Hawkins  M, Goulding  D, Cockburn  M, Green  AL.  Socioeconomics, race, and ethnicity in childhood cancer survival: accessing and addressing root causes of disparities.   Cancer. 2018;124(20):3975-3978. doi:10.1002/cncr.31558 PubMedGoogle ScholarCrossref
37.
Gupta  S, Aitken  JF, Bartels  U,  et al.  Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.   Lancet Oncol. 2016;17(4):e163-e172. doi:10.1016/S1470-2045(15)00539-2 PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    EXPAND ALL
    Relative Differences in Survival And Mortality Are Not the Same Thing
    James Scanlan, JD | Attorney at Law
    This article appears to fall within a large body of research that discusses relative differences in
    survival and relative differences in mortality interchangeably, often stating it is examining survival differences while in fact examining mortality differences. Invariably, such research has failed to recognize that that as survival generally increases, relative differences in survival tend to decrease while relative differences in mortality tend to increase, or that more survivable cancers tend to show smaller relative differences in survival but larger relative differences in mortality than less survivable cancers See reference 1 at 334 and the discussion of
    Tables 10 and 11 of reference 2. To my knowledge, no discussion of demographic differences in cancer outcomes has recognized that it is even possible for relative differences in survival and relative differences in mortality to show opposite patterns as to directions of changes over time or the comparative size of differences as to different types of cancers much less that this tends to occur systematically. The contrasting patterns may not always be present. But it is not possible to draw inferences about processes or the effects of interventions on demographic differences without recognizing the patterns or the problematic nature of the relative difference for either outcome as a measure of association.

    REFEFENCES

    1. Scanlan JP. Race and mortality revisited. Society 2014;51:327-346
    http://link.springer.com/article/10.1007%2Fs12115-014-9790-1#page-1
    2. Scanlan JP. Measuring health and healthcare disparities. Federal Committee on Statistical Methodology 2013 Research Conference (March 2014)
    http://www.copafs.org/UserFiles/file/fcsm/J4_Scanlan_2013FCSM.pdf
    CONFLICT OF INTEREST: None Reported
    READ MORE
    Original Investigation
    February 24, 2020

    Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability

    Author Affiliations
    • 1Medical Student, University of California, San Diego, School of Medicine, La Jolla
    • 2Brown School Master of Public Health Program, Washington University in St Louis, St Louis, Missouri
    • 3Medical Student, St Louis University School of Medicine, St Louis, Missouri
    • 4Siteman Cancer Center, Washington University in St Louis, St Louis, Missouri
    JAMA Pediatr. 2020;174(5):428-436. doi:10.1001/jamapediatrics.2019.6074
    Key Points

    Question  Are racial/ethnic disparities in childhood and adolescent cancer survival associated with treatment amenability?

    Finding  In this cohort study of 67 061 US children and adolescents, children and adolescents with racial/ethnic minority status had worse cancer survival compared with non-Hispanic white children and adolescents. Among non-Hispanic black and Hispanic (all races) children and adolescents, the disparity was generally greater for cancer types with higher vs lower relative survival rates.

    Meaning  Survival disparities among racial/ethnic minority children and adolescents appear to be greater for cancer types that are generally more amenable to medical intervention.

    Abstract

    Importance  Although US cancer survival rates have increased over time, disparities by race/ethnicity remain, including for children and adolescents.

    Objective  To examine whether racial/ethnic disparities in childhood and adolescent cancer survival vary by cancer type according to relative survival rates (RSRs), a marker for amenability to medical intervention.

    Design, Setting, and Participants  In a retrospective cohort study using US Surveillance, Epidemiology, and End Results data, 67 061 children and adolescents diagnosed at ages 0 to 19 years with a first primary malignant cancer from January 1, 2000, to December 31, 2016, were evaluated. Data analysis was performed from June 19 to November 3, 2019. Participants were followed up from the dates of diagnosis to cancer death or the end of the follow-up period, whichever came first.

    Exposures  Race/ethnicity defined as non-Hispanic white, non-Hispanic black, non-Hispanic American Indian/Alaskan Native, non-Hispanic Asian or Pacific Islander, or Hispanic (any race).

    Main Outcomes and Measures  Cancer amenability was defined using 5-year RSRs for 103 cancer types. Cox proportional hazards regression was used to compute adjusted hazard ratios (aHRs) and 95% CIs for the association between race/ethnicity and cancer survival for high (>85% RSR), medium (70%-85% RSR), and low (<70% RSR) amenability categories.

    Results  Among 67 061 cancer cases, 36 064 were male (53.8%); most individuals were non-Hispanic white (35 186 [52.5%]) followed by Hispanic of any race (19 220 [28.7%]), non-Hispanic black (7100 [10.6%]), non-Hispanic Asian or Pacific Islander (4981 [7.4%]), and non-Hispanic American Indian/Alaskan Native (574 [0.9%]). Mean (SD) age at diagnosis was 9.66 (6.41) years. Compared with non-Hispanic white children and adolescents, a higher aHR of death was observed for high- than low-amenability cancers for non-Hispanic black patients (high: aHR, 1.59; 95% CI, 1.41-1.80 vs low: aHR, 1.35; 95% CI, 1.24-1.47; P = .002 for interaction) and Hispanic (any race) patients (high: aHR, 1.63; 95% CI, 1.50-1.78 vs low: aHR, 1.16; 95% CI, 1.08-1.25; P < .001 for interaction). Results for other race/ethnicities showed similar patterns but were not statistically significant.

    Conclusions and Relevance  Racial/ethnic minority children and adolescents were observed to have a higher risk of death than non-Hispanic white children and adolescents, with more amenable cancers having larger relative survival differences. This disparity may be associated with a combination of factors, including differences in access to health care resources.

    ×